Literature DB >> 12192153

Characterization and quantitation of clarithromycin polymorphs by powder X-ray diffractometry and solid-state NMR spectroscopy.

Yuichi Tozuka1, Atsutoshi Ito, Hiroko Seki, Toshio Oguchi, Keiji Yamamoto.   

Abstract

Characterization of clarithromycin polymorph was performed by solid-state cross polarization and magic angle spinning (CP/MAS) 13C-NMR spectroscopy. Two polymorphs, form II and form I, of clarithromycins indicated characteristic resonances of C1 carbonyl carbon at 176.2 and 175.2 ppm, respectively. Since each peak of C1 carbon was well separated in the spectrum of the two polymorphs, we performed quantitative analysis of the polymorphic fraction from the peak area of these peaks. The peak area of form I was found to linearly increase with an increase of its content, with a correlation coefficient of above 0.99. Solid-state NMR was found to be a useful technique to determine the characteristics of the polymorphic forms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12192153     DOI: 10.1248/cpb.50.1128

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  4 in total

1.  Selective imaging of active pharmaceutical ingredients in powdered blends with common excipients utilizing two-photon excited ultraviolet-fluorescence and ultraviolet-second order nonlinear optical imaging of chiral crystals.

Authors:  S J Toth; J T Madden; L S Taylor; P Marsac; G J Simpson
Journal:  Anal Chem       Date:  2012-06-27       Impact factor: 6.986

2.  Molecular interaction among probucol/PVP/SDS multicomponent system investigated by solid-state NMR.

Authors:  Adchara Pongpeerapat; Kenjirou Higashi; Yuichi Tozuka; Kunikazu Moribe; Keiji Yamamoto
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

3.  Dissolution rate enhancement of clarithromycin using ternary ground mixtures: nanocrystal formation.

Authors:  Malihe Shahbaziniaz; Seyed Mohsen Foroutan; Noushin Bolourchian
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

4.  Characterization of olanzapine-solid dispersions.

Authors:  Venkateskumar Krishnamoorthy; Arunkumar Nagalingam; Verma Priya Ranjan Prasad; Siva Parameshwaran; Neema George; Punitha Kaliyan
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.